← Back to Clinical Trials
Recruiting NCT06514677

NCT06514677 Non-Surgical Treatment of Peri-Implantitis With Ultrasonic Carbon Tip

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06514677
Status Recruiting
Phase
Sponsor Kutahya Health Sciences University
Condition Peri-Implantitis
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-12-01
Primary Completion 2025-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Ultrasonic Carbon TipTitanium Curette

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2023-12-01 with a primary completion date of 2025-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

As the frequency of dental implants increases, the incidence of complications and peri-implant diseases also increases. Early diagnosis and treatment of the disease is important to prevent consequences up to implant loss. Non-surgical treatment is the recommended treatment in the first stage due to its shorter duration and low morbidity rate. Non-surgical treatment of peri-implantitis provides clinical improvements such as reduced bleeding on probing (20-50%) and, in some cases, reduced pocket depth (≤ 1 mm). This study aims to clinically and radiographically compare two different mechanical treatments in patients with mild and moderate peri-implantitis.

Eligibility Criteria

Inclusion criteria: 1. Adult patients (≥18 years old) 2. Systemically healthy (ASA class 1 and ASA class 2) 3. Full-mouth plaque scores ≤20% 4. Implant had been in function for more than 6 months 5. Absence of plaque around the implant 6. Consent to complete all follow-up visits Exclusion criteria: 1. Mobile implant 2. Overhanging restorations that prevent access to the implant for clinical measurements 3. Unresolvable technical complications that can cause peri-implantitis 4. Presence of active periodontal disease 5. Implants with a history of peri-implantitis treated using graft materials 6. Use of drugs that cause gingival hyperplasia 7. Systemic antibiotic use in the last 3 months 8. Acute and chronic medical conditions that prevent the patient from participating in the study 9. Presence of uncontrolled severe peri-implantitis from neighbouring implants 10. History of radiotherapy in the head and neck region 11. Receiving acute chemotherapy 12. Current corticosteroid therapy

Contact & Investigator

Central Contact

Berceste Guler Ayyildiz, d

✉ berceste.guler@ksbu.edu.tr

📞 +90 (274) 260 00 43

Frequently Asked Questions

Who can join the NCT06514677 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Peri-Implantitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06514677 currently recruiting?

Yes, NCT06514677 is actively recruiting participants. Contact the research team at berceste.guler@ksbu.edu.tr for enrollment information.

Where is the NCT06514677 trial being conducted?

This trial is being conducted at Kütahya, Turkey (Türkiye).

Who is sponsoring the NCT06514677 clinical trial?

NCT06514677 is sponsored by Kutahya Health Sciences University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology